Derbend Asset Management’s Pfizer PFE Stock Holding History

Derbend Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$284K	Sell	10,232 -447	-4%	-$12.4K	0.14%	94
2023 Q4	$307K	Sell	10,679 -165	-2%	-$4.99K	0.18%	81
2023 Q3	$360K	Sell	10,844 -547	-5%	-$19.3K	0.25%	73
2023 Q2	$418K	Sell	11,391 -1,350	-11%	-$52.5K	0.28%	48
2023 Q1	$520K	Sell	12,741 -873	-6%	-$37.7K	0.39%	39
2022 Q4	$698K	Sell	13,614 -1,054	-7%	-$50.5K	0.56%	36
2022 Q3	$642K	Buy	14,668 +32	+0.2%	+$1.55K	0.51%	37
2022 Q2	$767K	Sell	14,636 -1,850	-11%	-$94.3K	0.64%	31
2022 Q1	$974K	Hold	16,486	–	–	0.95%	34
2021 Q4	$974K	Sell	16,486 -192	-1%	-$9.51K	0.95%	34
2021 Q3	$717K	Sell	16,678 -736	-4%	-$32.6K	0.67%	44
2021 Q2	$682K	Buy	+17,414	New	+$677K	0.64%	48

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Derbend Asset Management's PFE Position: Q1 2024 in Review

Derbend Asset Management reduced its Pfizer (PFE) stake by 4.2% in Q1 2024, selling an estimated $12.4K and leaving 10,232 shares worth $284K. The position accounts for 0.14% of the portfolio, ranked #94.

Derbend Asset Management first reported a position in PFE in Q2 2021 and has held it in 12 quarters since. The position peaked at $974K in Q1 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Derbend Asset Management held 10,232 shares of Pfizer worth $284K as of Q1 2024.
Derbend Asset Management sold 447 Pfizer shares in Q1 2024, an estimated $12.4K.
Pfizer made up 0.14% of Derbend Asset Management's portfolio in Q1 2024, its #94 holding.
Derbend Asset Management first reported a position in Pfizer in Q2 2021 and has held it in 12 quarters since.
Derbend Asset Management's Pfizer position peaked at $974K in Q1 2022.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Derbend Asset Management's 13F filing for Q1 2024, filed 30 Apr 2024.